Want to join the conversation?
Excluding 3Q14 clinical trials revenue, $DGX's consolidated revenue was $1.88Bil, up by 0.9% vs. 3Q14 on an equivalent revenue basis. GAAP reported revenues were lower by 1.3%, while diagnostic information services revenue was flat to prior year. Revenue per acquisition was 0.2% better than 3Q14.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.